526 related articles for article (PubMed ID: 18430132)
1. Liposomal amphotericin B: what is its role in 2008?
Lanternier F; Lortholary O
Clin Microbiol Infect; 2008 May; 14 Suppl 4():71-83. PubMed ID: 18430132
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
3. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
4. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
5. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
6. [New aspects in treatment of systemic mycoses].
Presterl E; Graninger W
Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
8. [Guideline based treatment of invasive aspergillosis].
Karthaus M
Mycoses; 2010 May; 53 Suppl 1():36-43. PubMed ID: 20433655
[TBL] [Abstract][Full Text] [Related]
9. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
10. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
Rogers TR; Frost S
Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in antifungal chemotherapy.
Petrikkos G; Skiada A
Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
[TBL] [Abstract][Full Text] [Related]
12. Update on antifungal treatment of invasive Candida and Aspergillus infections.
Maschmeyer G; Ruhnke M
Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328
[TBL] [Abstract][Full Text] [Related]
13. The current role of amphotericin B lipid complex in managing systemic fungal infections.
Chu P; Sadullah S
Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
[TBL] [Abstract][Full Text] [Related]
15. Antifungal treatment strategies in high risk patients.
Rüping MJ; Vehreschild JJ; Cornely OA
Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
Brogden RN; Goa KL; Coukell AJ
Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
[TBL] [Abstract][Full Text] [Related]
17. Fungal infections in cancer patients: an escalating problem.
Samonis G; Bafaloukos D
In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
[TBL] [Abstract][Full Text] [Related]
18. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.
Cornely OA
Infection; 2008 Aug; 36(4):296-313. PubMed ID: 18642109
[TBL] [Abstract][Full Text] [Related]
19. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
20. Changing strategies for treatment of systemic mycoses.
Graybill JR
Braz J Infect Dis; 2000 Apr; 4(2):47-54. PubMed ID: 11012295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
